Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Finn

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Developmental Medicine and Child Neurology|February 10, 2025
Reproducibility of the Motor Optimality Score-Revised in infants with an increased risk of adverse neurodevelopmental outcomesCarly Luke, Arend F Bos, Michelle Jackman, et al.
Therapeutic Advances in Infectious Disease|January 5, 2023
Improving care for individuals with serious infections who inject drugsColleen Kershaw, Jon D Lurie, Charles Brackett, et al.
BMC Neurology|June 14, 2013
Australian Cerebral Palsy Child Study: protocol of a prospective population based study of motor and brain development of preschool aged children with cerebral palsyRoslyn N Boyd, Rachel Jordan, Laura Pareezer, et al.
Surgical Oncology|November 27, 2022
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancerJames V Pellicane, Peter D Beitsch, David T Rock, et al.
JCO Precision Oncology|September 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant TherapyPat W Whitworth, Peter D Beitsch, Mary K Murray, et al.
BMJ Open|July 15, 2017
PREDICT-CP: study protocol of implementation of comprehensive surveillance to predict outcomes for school-aged children with cerebral palsyRoslyn N Boyd, Peter Sw Davies, Jenny Ziviani, et al.
Annals of Surgical Oncology|April 5, 2022
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast CancerPat Whitworth, Peter D Beitsch, James V Pellicane, et al.
JCO Precision Oncology|April 27, 2022
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene SignaturePat W Whitworth, Peter D Beitsch, James V Pellicane, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Developmental Medicine and Child Neurology|February 10, 2025
Reproducibility of the Motor Optimality Score-Revised in infants with an increased risk of adverse neurodevelopmental outcomesCarly Luke, Arend F Bos, Michelle Jackman, et al.
Therapeutic Advances in Infectious Disease|January 5, 2023
Improving care for individuals with serious infections who inject drugsColleen Kershaw, Jon D Lurie, Charles Brackett, et al.
BMC Neurology|June 14, 2013
Australian Cerebral Palsy Child Study: protocol of a prospective population based study of motor and brain development of preschool aged children with cerebral palsyRoslyn N Boyd, Rachel Jordan, Laura Pareezer, et al.
Surgical Oncology|November 27, 2022
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancerJames V Pellicane, Peter D Beitsch, David T Rock, et al.
JCO Precision Oncology|September 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant TherapyPat W Whitworth, Peter D Beitsch, Mary K Murray, et al.
BMJ Open|July 15, 2017
PREDICT-CP: study protocol of implementation of comprehensive surveillance to predict outcomes for school-aged children with cerebral palsyRoslyn N Boyd, Peter Sw Davies, Jenny Ziviani, et al.
Annals of Surgical Oncology|April 5, 2022
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast CancerPat Whitworth, Peter D Beitsch, James V Pellicane, et al.
JCO Precision Oncology|April 27, 2022
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene SignaturePat W Whitworth, Peter D Beitsch, James V Pellicane, et al.
Pageof 2